BACKGROUND: Heterotopic ossification (HO) is the pathologic process of extraskeletal bone formation. Although the exact etiology remains unknown, inflammation appears to catalyze disease progression. The goal of this study is to determine the impact of the adaptive immune system on HO. METHODS: HO was induced in 8-wk-old control C57BL/6 and immunocompromised Rag1tm1Mom (Rag1 KO) male mice deficient in B- and T-lymphocytes via combined Achilles tenotomy and burn injury. Microcomputed tomography quantified the extent of HO formation at the tenotomy site. Adipose-derived mesenchymal stem cells were harvested to evaluate osteogenic differentiation potential. RESULTS: Areas of developing HO demonstrated substantial enrichment of CD45 + leukocytes at 3 wk after injury. HO from Rag1 KO mice was substantially less mature with foci of cartilage and disorganized trabecular bone present 12 wk after injury. Rag1 KO mice formed 60% less bone compared to immunocompetent controls (4.67 ± 1.5 mm versus 7.76 ± 0.65 mm; P = 0.001). Tartrate-resistant acid phosphatase staining and immunofluorescent analysis of osteoprotegerin and nuclear factor kappa-light-chain-enhancer of activated B cells demonstrated no appreciable difference in osteoclast number or activation. Alizarin red staining in vitro demonstrated a significant decrease in osteogenic potential in immunocompromised mice compared to controls (29.1 ± 0.54 mm versus 12.1 ± 0.14 mm; P < 0.001). CONCLUSIONS: We demonstrate a prominent role for the adaptive immune system in the development of HO. In the absence of mature B- and T-lymphocytes, HO growth and development are attenuated. Furthermore, we demonstrate that mesenchymal populations from B- and T-cell deficient mice are inherently less osteogenic. This study identifies a potential therapeutic role for modulation of the adaptive immune system in the treatment of HO.
BACKGROUND:Heterotopic ossification (HO) is the pathologic process of extraskeletal bone formation. Although the exact etiology remains unknown, inflammation appears to catalyze disease progression. The goal of this study is to determine the impact of the adaptive immune system on HO. METHODS: HO was induced in 8-wk-old control C57BL/6 and immunocompromised Rag1tm1Mom (Rag1 KO) male mice deficient in B- and T-lymphocytes via combined Achilles tenotomy and burn injury. Microcomputed tomography quantified the extent of HO formation at the tenotomy site. Adipose-derived mesenchymal stem cells were harvested to evaluate osteogenic differentiation potential. RESULTS: Areas of developing HO demonstrated substantial enrichment of CD45 + leukocytes at 3 wk after injury. HO from Rag1 KO mice was substantially less mature with foci of cartilage and disorganized trabecular bone present 12 wk after injury. Rag1 KO mice formed 60% less bone compared to immunocompetent controls (4.67 ± 1.5 mm versus 7.76 ± 0.65 mm; P = 0.001). Tartrate-resistant acid phosphatase staining and immunofluorescent analysis of osteoprotegerin and nuclear factor kappa-light-chain-enhancer of activated B cells demonstrated no appreciable difference in osteoclast number or activation. Alizarin red staining in vitro demonstrated a significant decrease in osteogenic potential in immunocompromised mice compared to controls (29.1 ± 0.54 mm versus 12.1 ± 0.14 mm; P < 0.001). CONCLUSIONS: We demonstrate a prominent role for the adaptive immune system in the development of HO. In the absence of mature B- and T-lymphocytes, HO growth and development are attenuated. Furthermore, we demonstrate that mesenchymal populations from B- and T-cell deficient mice are inherently less osteogenic. This study identifies a potential therapeutic role for modulation of the adaptive immune system in the treatment of HO.
Authors: Gabriel J Pavey; Elizabeth M Polfer; Kyle E Nappo; Scott M Tintle; Jonathan A Forsberg; Benjamin K Potter Journal: Clin Orthop Relat Res Date: 2015-09 Impact factor: 4.176
Authors: Gabriel J Pavey; Ammar T Qureshi; Donald N Hope; Rebecca L Pavlicek; Benjamin K Potter; Jonathan A Forsberg; Thomas A Davis Journal: Clin Orthop Relat Res Date: 2015-09 Impact factor: 4.176
Authors: Jonathan A Forsberg; Benjamin K Potter; Elizabeth M Polfer; Shawn D Safford; Eric A Elster Journal: Clin Orthop Relat Res Date: 2014-05-31 Impact factor: 4.176
Authors: Jonathan Agner Forsberg; Joseph M Pepek; Scott Wagner; Kevin Wilson; James Flint; Romney C Andersen; Doug Tadaki; Frederick A Gage; Alexander Stojadinovic; Eric A Elster Journal: J Bone Joint Surg Am Date: 2009-05 Impact factor: 5.284
Authors: V I Sakellariou; E Grigoriou; A F Mavrogenis; P N Soucacos; P J Papagelopoulos Journal: J Musculoskelet Neuronal Interact Date: 2012-12 Impact factor: 2.041
Authors: Qizhi Qin; Mario Gomez-Salazar; Masnsen Cherief; Chase A Pagani; Seungyong Lee; Charles Hwang; Robert J Tower; Sharon Onggo; Yuxiao Sun; Abhinav Piplani; Zhao Li; Sowmya Ramesh; Thomas L Clemens; Benjamin Levi; Aaron W James Journal: Bone Res Date: 2022-06-01 Impact factor: 13.362